Marc Engelhardt is Chief Medical Officer of Basilea Pharmaceutica AG.
Dr. Engelhardt previously held the position of Director-Global Program Medical at Novartis Pharma AG.
Dr. Engelhardt received an undergraduate degree and a doctorate from Johann Wolfgang Goethe-Universität Frankfurt am Main.
|